Press room

12th March 2012
Combinatorial domain hunting technology aids identification of MEK protein suitable for structure-based drug discovery New structural information allowed UCB scientists to design a novel class of molecules which inhibit MEK
29th November 2011
Domainex to Present at a Range of Industry Events in December 2011, including Epigenetics Summit in Munich, including:
8th November 2011
This is to recognise its work on the development of a new cancer drug against the novel kinase targets TBK1/IKKe.
1st November 2011
Domainex has been awarded a £250,000 grant by the Technology Strategy Board to support development of a new drug for treatment of several common cancers.
6th April 2011
Cambridge Business Media Interview (External link)
7th March 2011
Business Weekly Interview (External link)
7th March 2011
Domainex Ltd, a biotechnology company providing world-class drug discovery services to support both its own and customer research programmes, has announced plans to significantly expand its medicinal chemistry and biology capabilities in 2011.
7th January 2011
Scientists at St George’s, University of London and the University of Manchester have received an additional Seeding Drug Discovery award of £390,000 from the Wellcome Trust to explore a new class of experimental drugs that block the trigger of allergic reactions before symptoms show. Domainex will provide medicinal chemistry services and advice to support the consortium.

Pages